Sulfapyridine

磺胺吡啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfapyridine
Drug Alias NameSulfapiridinaSulfapyridinSulfapyridiiniSulphapyridineSulfapyridinum
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDermatitis
Global Approved IndicationsDermatitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1939/03/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDermatitis

Other Information

ATC CodeJ01EB04
Related LinksWikipediaDrugBankKEGG